Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Oncology|March 1, 1997
Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I studyT Schilling, B Heinrich, R Kau, et al.Investigational New Drugs|January 1, 1996
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitaneT Schilling, K B Keppler, M E Heim, et al.Lipids|November 1, 1987
Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitroM Fromm, W E Berdel, H D Schick, et al.Deutsche Medizinische Wochenschrift (1946)|February 22, 1985
[Possibilities and limitations of computerized tomography in the staging of the subdiaphragmatic spread of Hodgkin's disease]S Feuerbach, M Reiser, U Fink, et al.European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Preclinical activity of trans-indazolium[tetrachlorobisindazoleruthenate(III)] (NSC 666158; IndCR; KP 1019) against tumour colony-forming units and haematopoietic progenitor cellsH Depenbrock, S Schmelcher, R Peter, et al.Cancer Research|February 1, 1983
Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cellsW E Berdel, E Greiner, U Fink, et al.Anticancer Research|May 1, 1988
Influence of phase I early clinical trials on the quality of life of cancer patients. A pilot studyW E Berdel, H Knopf, M Fromm, et al.Blut|February 1, 1983
Conversion of an IGM secreting immunocytoma in a high grade malignant lymphoma of immunoblastic typeB Emmerich, M Pemsl, I Wüst, et al.Cancer|November 15, 1982
Early tumor and leukemia response to alkyllysophospholipids in a phase I studyW E Berdel, H Schlehe, U Fink, et al.Seminars in Oncology|December 1, 1995
Clinical phase I study of paclitaxel followed by cisplatin in advanced head and neck squamous cell carcinomaA R Hanauske, T Schilling, B Heinrich, et al.Pageof 7